Improving Glycemic Control With Telemedicine and Smart Insulin Pens — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving Glycemic Control With Telemedicine and Smart Insulin Pens — Stella

Home/Diabetes Mellitus/

View on ClinicalTrials.gov

Recruiting

Back to Diabetes Mellitus trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Baltimore VA Maryland Center, Baltimore, Maryland

VAMHCS, Diabetes Outpatient Clinic, Baltimore, Maryland

Key details

Sponsor

University of Maryland, Baltimore

Collaborators

Medtronic

Enrollment target

~50 participants

Started

January 2026

Primary completion

May 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.